Real-time enrollment status for this colorectal adenocarcinoma metastatic in the liver clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 7:18 PM UTC
| NCT Number | NCT07082439 |
| Recruiting Status | Recruiting |
| Condition | Colorectal Adenocarcinoma Metastatic in the Liver |
| Phase | PHASE2 |
| Target Enrollment | 27 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Abramson Cancer Center at Penn Medicine |
| Last Updated on CT.gov | September 22, 2025 (Sep 22, 2025) |
As of July 18, 2026: Clinical trial NCT07082439 is currently recruiting participants. This phase2 study for colorectal adenocarcinoma metastatic in the liver is actively seeking new participants at 1 location across the United States. The study is sponsored by Abramson Cancer Center at Penn Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07082439 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07082439 was last updated Sep 22, 2025 (September 22, 2025). HelloStudys verifies this status automatically.